2015 Oncology Nursing Drug Handbook / Edition 19

by Gail M. Wilkes, Margaret Barton-Burke

Overview

Written especially for nurses caring for patients with cancer, the 2015 Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. Updated annually, this essential reference provides valuable information on effective symptom management, patient education, and chemotherapy administration.

Completely revised and updated, the 2015 Oncology Nursing Drug Handbook includes a simplified chapter on molecular and biological targeted therapy that incorporates new information about immunotherapy, new indications, and the most important and common side effects.

New drug entries include: afatinib, belinostat, ceritinib, ibrutinib, idelalisib, obinutuzumab, pembrolizumab, ramucirumab, siltuximab, and mercaptopurine oral suspension.

Product Details

ISBN-13:	9781284059298
Publisher:	Jones & Bartlett Learning
Publication date:	01/02/2015
Edition description:	Older Edition
Pages:	1484
Product dimensions:	5.50(w) x 8.40(h) x 2.20(d)

About the Author

Oncology Nursing Consultant, Kilauea, Hawaii


Mary Ann Lee Professor of Oncology Nursing, University of Missouri, St. Louis, Research Scientist, Siteman Cancer Center

Table of Contents

Section I Cancer Treatment
Chapter 1 Introduction to Chemotherapy Drugs
Chapter 2 Biologic Response Modifier Therapy
Chapter 3 Cytoprotective Agents
Chapter 4 Molecularly Targeted Therapies
Chapter 5 Chemobiotherapy for Noncancer Diseases
Section II Symptom Management
Chapter 6 Pain
Chapter 7 Nausea and Vomiting
Chapter 8 Anorexia and Cachexia
Chapter 9 Anxiety and Depression
Section III Complications
Chapter 10 Managing Tumor-Related Skeletal Events and Hypercalcemia
Chapter 11 Infection
Chapter 12 Constipation
Chapter 13 Diarrhea
Appendix 1 Occupational Exposure to Hazardous Drugs
Appendix 2 Common Terminology Criteria for Adverse Events (CTCAE)